Cherreads

Chapter 443 - Chapter 443: Treating the Inductii

Chapter 443: Treating the Inductii

Ryo's mechanical tentacles plugged into the main cogitator array of the Apothecarion on the "Phalanx", beginning to systematically analyze the compensatory mechanisms formed within the bodies of the Inductii warriors.

Relying on his deep understanding of the original physiological design of the Space Marines, his processing core rapidly compared a series of key parameters.

"The core of the problem lies in the compensatory imbalance of the neuroendocrine system," Ryo's synthesized voice calmly stated the analysis results.

The holographic projection displayed the physiological data streams of the test subjects in real-time. "The prolonged lack of the regulatory functions of the Sus-an Membrane has caused the hypothalamic-pituitary-adrenal axis to remain in a state of continuous hyperactivity."

Magos Alvaro Vis brought up the corresponding hormone monitoring charts to verify: "The data shows that the baseline cortisol levels of these warriors are about forty percent higher than the standard value."

"This is precisely the key factor triggering the rejection reaction," Chief Apothecary Torgal added, pointing to the functional readings of the newly implanted organs. "An overactive endocrine system cannot adapt to the normal regulatory rhythms brought by the Sus-an Membrane."

Based on these findings, Ryo formulated a phased treatment plan. He first selected three Inductii warriors with milder symptoms as the first batch of treatment subjects.

These warriors only exhibited intermittent body temperature fluctuations and slight motor coordination disorders, and had not yet developed severe organ dysfunction.

The treatment commenced in a sterile medical pod adjacent to the Apothecarion. Ryo personally operated the precision drug delivery system while monitoring the changes in the subjects' physiological signals in real-time through multi-channel neural interfaces.

"Commence infusion of neuromodulatory inhibitors, initial dosage set to seventy percent of the standard value," Ryo commanded the assisting Apothecary servitors.

The transparent liquid medicine was slowly injected into the first warrior's circulatory system via a precision pump.

At the same time, Ryo began adjusting the environmental parameters: "Lower the medical pod temperature by two degrees Celsius to partially simulate the thermoregulatory function of the Sus-an Membrane."

During the subsequent treatment process, Ryo continuously paid attention to the dynamic changes in various physiological indicators.

Based on real-time feedback data, he fine-tuned the treatment protocol every twenty minutes.

"The thyroid hormone levels of Warrior Number 742 are beginning to normalize," Magos Vis reported the latest monitoring results. "The heart rate variability index has improved significantly, reaching fifteen percent."

Apothecary Torgal examined the tissue biopsy samples: "The concentration of inflammatory factors has dropped significantly, and the cell necrosis process has been effectively contained."

"Initiate the gene-seed calibration sequence, using the alpha band frequency," Ryo inputted the updated parameters into the main control system.

Inside the medical pod, a special bio-energy field began to act upon the test subjects.

This technology drew inspiration from Lady Astarte's original design theories regarding gene-seed synergy, aiming to promote the integration of the newly implanted organs with the host's gene-seed.

After six hours of treatment, the physiological indicators of the three warriors gradually stabilized.

Hormone levels returned to the normal range, the rejection reactions in neural tissues were significantly reduced, and thermoregulatory functions progressively recovered.

"Acute rejection reactions have been brought under control," Ryo summarized the treatment results. "But this is only a phased achievement. The remodeling of the compensatory mechanisms requires a longer cycle."

Apothecary Torgal carefully recorded the complete treatment data: "At the very least, we have verified the correctness of our treatment direction. The health condition of these warriors has stopped deteriorating."

"This protocol can be extended to other mild cases. However, for severe patients, the treatment strategy may need to be adjusted," Magos Vis began organizing the medical files.

Ryo disconnected from the medical equipment. "Next, a twenty-four-hour observation is required. If the situation remains stable, we can begin the second batch of treatments."

The indicator lights on the medical pods changed from a warning red to a steady green, marking that the first batch of treated warriors was temporarily out of danger.

The Tech-Priests within the Apothecarion began preparing the necessary medical instruments and drug reserves for the subsequent treatment cycles.

After stabilizing the acute symptoms of the majority of the Inductii warriors, Ryo set out to resolve the root problems that led to the rejection reactions.

His treatment plan was divided into two distinct phases.

The first phase focused on adjusting the existing physiological states of the warriors.

Based on the specific conditions of each warrior, Ryo formulated customized pharmaceutical formulas.

He used specially made neuromodulators to balance the functional activity of the hypothalamic-pituitary-adrenal axis, while simultaneously simulating part of the Sus-an Membrane's functions through environmental control.

"Continuously monitor cortisol and adrenaline levels," Ryo instructed the assisting Apothecary servitors. "Maintain thyroxine at eighty-five percent of the standard range."

During the treatment process, Ryo noticed significant differences in how different warriors responded to the medications.

Some warriors' hormone levels rapidly stabilized after administration, while others required repeated dosage adjustments.

He paid special attention to those cases with more stubborn compensatory mechanisms, establishing independent medical files for each warrior.

While regulating hormones, Ryo proceeded to treat the already implanted organs.

He used a low-intensity bio-energy field to gently stimulate the organ tissues, promoting their connection with the host's neural network.

This process required extremely precise control. The intensity of the energy field had to be just right—enough to activate organ functions, but not so much as to trigger new rejection reactions.

"Current organ activity has reached sixty percent of the expected value," Magos Vis reported the latest data. "Neural connection stability has improved by twenty-five percent compared to before treatment."

The second phase of the work was to cultivate new, customized organs.

Ryo extracted genetic samples from each warrior and began customized cultivation in the biological laboratories of the "Phalanx".

Unlike the previous standard templates, this time he fine-tuned the genetic sequences of the Sus-an Membrane and Betcher's Gland based on each warrior's unique physiological parameters.

"The cultivation process must remain synchronized with the warriors' gene-seed," Ryo explained to Apothecary Torgal. "Only in this way can we ensure the new organs are fully accepted."

While waiting for the new organs to be cultivated, Ryo continued to optimize the warriors' physiological states.

He gradually reduced the medication dosages, observing the warriors' autonomous regulatory capabilities.

The endocrine systems of most warriors began to show normal self-regulatory functions, indicating that the compensatory patterns were gradually being eliminated.

"The hormone levels of Warrior Number 763 have remained stable for seventy-two consecutive hours," Apothecary Torgal reported. "We can begin preparing for the organ transplant surgery."

Ryo checked the latest data of this warrior, confirming that his physiological state had indeed met the surgical standards.

Simultaneously, the biological laboratory also completed the cultivation of the corresponding customized organs.

"Commence the first customized organ transplant," Ryo issued the command.

The surgery took place inside a sterile medical pod on the "Phalanx".

Ryo personally performed the operation. His mechanical arms completed the implantation of the new organs with astonishing precision.

Throughout the entire process, the vital monitoring systems showed that the warrior's physiological indicators remained stable.

With the successful implantation of the first customized organ, Ryo's treatment plan received preliminary validation.

Next, they needed to observe the integration of the new organs with the host, which would determine the direction of subsequent treatments.

More Chapters